More than half the country’s health boards have blown out their budgets just months into the new financial year, Labour’s Health spokesperson Annette King says.
“A report to Jonathan Coleman on the financial performance of our district health boards shows that in just the second month of the 2015/16 financial year 13 are in the red to the tune of $8.4 million.
The Government snubbed advice from its chief child health adviser to set an obesity target in favour of soft pedalling in the interests of big business, Labour’s Acting Health spokesperson David Clark says.
“Buried in a report to Jonathan Coleman – uncovered in a Government document dump – Pat Tuohy, a specialist paediatrician and the go-to adviser for the Government on child health, recommends establishing a healthy weight target for four-year-old pre-schoolers using BMI and waist circumference as a better public services target.
Labour is calling for Health Minister Jonathan Coleman to set up a register so that people who believe they may have been exposed to asbestos at Dunedin Hospital can be assessed and monitored if they wish.
“Positive tests have revealed asbestos on four floors of the hospital, in both work rooms and public areas,” Labour’s Associate Health spokesperson David Clark says.
Increasing numbers of people with mental health-related issues are turning to emergency departments for help as funding dries up across the country, Labour’s Associate Health Spokesperson David Clark says.
“Figures obtained by Labour show the number of people presenting to emergency departments as a result of mental health issues have more than tripled in the last four years.
Tim Groser is not being upfront with Kiwis about what the TPP will mean with regards to life-saving drug costs, Labour’s Acting Leader and Health spokesperson Annette King says.
“Claims by Mr Groser that Kiwis won’t be paying more for their medicine under the TPP should be taken with a large dose of scepticism. He let the Australians do the running on this, while he concentrated on dairy. The result is a dud deal for dairy and a less than clear proposal on drug costs.